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Background-—An analysisof the changesin the clinicaland demographic characteristics of patients with acutemyocardial infarction
couldidentifysuccessesandfailuresofriskfactor identiﬁcation andtreatmentofpatientsatincreased riskforcardiovascular events.
Methods and Results-—We reviewed data collected from 138 122 patients with acute myocardial infarction admitted from 2003
to 2008 to hospitals participating in the American Heart Association Get With The Guidelines Coronary Artery Disease program.
Clinical, demographic, and laboratory characteristics were analyzed for each year stratiﬁed on the electrocardiogram at
presentation. Patients with non–ST-segment–elevation myocardial infarction were older, more likely to be women, and more likely
to have hypertension, diabetes mellitus, and a history of past cardiovascular disease than were patients with ST-elevation
myocardial infarction. In the overall patient sample, signiﬁcant trends were observed of an increase over time in the proportions of
non–ST-segment–elevation myocardial infarction, patient age of 45 to 65 years, obesity, and female sex. The prevalence of
diabetes mellitus decreased over time, whereas the prevalences of hypertension and smoking were substantial and unchanging.
The prevalence of “low” high-density lipoprotein increased over time, whereas that of “high” low-density lipoprotein decreased.
Stratum-speciﬁc univariate analysis revealed quantitative and qualitative differences between strata in time trends for numerous
demographic, clinical, and biochemical measures. On multivariable analysis, there was concordance between strata with regard to
the increase in prevalence of patients 45 to 65 years of age, obesity, and “low” high-density lipoprotein and the decrease in
prevalence of “high” low-density lipoprotein. However, changes in trends in age distribution, sex ratio, and prevalence of smokers
and the magnitude of change in diabetes mellitus prevalence differed between strata.
Conclusions-—There were notable differences in risk factors and patient characteristics among patients with ST-elevation
myocardial infarction and those with non–ST-segment–elevation myocardial infarction. The increasing prevalence of dysmetabolic
markers in a growing proportion of patients with acute myocardial infarction suggests further opportunities for risk factor
modiﬁcation. (J Am Heart Assoc. 2012;1:e001206 doi: 10.1161/JAHA.112.001206)
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D
escription of the behavioral, environmental, and genetic
factors in patients with acute myocardial infarction
(AMI) underscores our current understanding of the causal
relationship between patient- and population-speciﬁc expo-
sures, or risk factors, and clinical outcomes.
1–4 Patients with
AMI represent a distinct, highly select subgroup of the general
population. Changes in the extent and distribution of speciﬁc
clinical, demographic, and biochemical factors over time in
patients with AMI provide insight into the overall burden of
disease in individuals at the highest risk for AMI. The latter is
of relevance from demographic and public health perspec-
tives, given the increasing number of individuals in the general
population at risk for AMI
5 and the increasing number of
survivors of AMI.
6 Finally, such studies, by revealing an
increased or unchanging presence of speciﬁc risk factors,
could suggest additional or missed opportunities for pre-
ventive strategies.
7,8
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ORIGINAL RESEARCHIn the present analysis from the American Heart Associ-
ation (AHA) Get With The Guidelines Coronary Artery Disease
(GWTG-CAD) program, we report the prevalences of clinical,
demographic, and biochemical factors in patients presenting
with AMI and the changes in those prevalences from 2003 to
2008.
Methods
The AHA GWTG-CAD Program
The mission, scope, and purpose of the AHA GWTG-CAD
program have been described previously.
9,10 Because GWTG-
CAD is a quality-improvement program, hospitals are
encouraged to consecutively enroll all eligible patients. The
GWTG-CAD population includes all patients admitted to the
hospital who were subsequently discharged with a diagnosis of
AMI, unstable angina, chronic stable angina, or ischemic heart
disease (International Classiﬁcation of Diseases, Ninth Revi-
sion, Clinical Modiﬁcation [ICD-9-CM] codes 410–414). Each
participating site is responsible for its own data collection and
uploading. Data quality is monitored in a Web-based system,
and reports are provided to the site to ensure completeness
and accuracy of the submitted data. Data collected include
patient demographics, medical history, symptoms on arrival,
results of laboratory testing, in-hospital treatment and events,
discharge treatment and counseling, and patient disposition.
The de-identiﬁcation of patients occurs at this level.
All participating institutions were required to comply with
local regulatory and privacy guidelines and to submit the
GWTG-CAD protocol for review and approval by their institu-
tional review boards. Because data were used primarily at the
local site for quality improvement, sites were granted a waiver
of informed consent under the common rule. The Duke
Clinical Research Institute (Durham, NC) serves as the data
analysis center and has institutional review board approval to
analyze the aggregate de-identiﬁed data for research
purposes.
Patient Population
The GWTG-CAD program began in 2000, and the length of
participation of each hospital depended on the time it entered
the program. Baseline data included the ﬁrst 30 admissions
for each participating site and served as the entry point into
the study. Subsequently, participation time was calculated in
calendar quarters. Quarters with <1000 admissions were
excluded to obtain reliable estimates of trends over time; this
necessitated exclusion of data obtained in all 4 quarters of
2000 and 2001. Therefore, all GWTG-CAD–participating
hospitals enrolled from January 1, 2002, to April 2010 were
eligible for analysis.
The patient sample for this study was derived from the
population of patients with a ﬁrst-listed diagnosis and
supporting ICD-9-CM code for coronary heart disease who
were admitted to hospitals participating in the AHA GWTG-
CAD program. Data from January 2002 through April 2010
were reviewed. Over this interval, 282 585 patients had an
ICD-9-CM–consistent diagnosis of AMI (ICD-9-410). Excluded
were records created before 2003 (n=23 024), records
created after 2008 because of administrative changes in the
GWTG program (n=16 396), patients with heart failure with
CAD (n=36 574), patients without an AMI (n=66 940), and
patients with an unspeciﬁed AMI (n=1529). The ﬁnal study
sample consisted of 138 122 patients (from 398 sites)
admitted from January 1, 2003, to December 31, 2008.
Patients subsequently were categorized by the electrocardio-
gram pattern on admission: speciﬁcally, those with ST-
segment–elevation myocardial infarction (STEMI; n=44 172)
or a new or presumably new left bundle-branch block pattern
and those without ST-segment elevation (NSTEMI; n=92 950).
Data and Statistical Analysis
Data are presented as means ± standard deviations or
medians and interquartile ranges (IQRs) for continuous
variables and as percentages for categorical variables for
the overall data set and separately for the STEMI and NSTEMI
strata. Univariate associations between categorical variables
and year of observation (ordered variable) were tested with v
2
statistics (for >3 levels per categorical variable) and Wilcoxon
rank-based statistics (for 2 levels per category). The overall
effect of linear yearly trend for each variable of interest was
tested with the Cochran-Mantel-Haenszel method. P values
for continuous data are based on v
2 1-degree-of-freedom rank
correlation statistics. Stratum-speciﬁc multivariable logistic
regression was performed to assess the association of time
and the following dichotomous risk factors for AMI: age, sex,
history of hypertension, history of prior myocardial infarction,
history of treated diabetes mellitus, history of current or
recent smoking, obesity (body mass index [BMI] >30 kg/m
2),
dyslipidemia (low-density lipoprotein [LDL] >100 mg/dL;
high-density lipoprotein [HDL] <40 mg/dL for men,
<50 mg/dL for women; triglycerides >150 mg/dL). Because
patients admitted to the same hospital can have similar
characteristics, the generalized estimating equations method
with an exchangeable working correlation structure was used
to adjust for within-hospital clustering.
11 The generalized
estimating equations method is only one analytical strategy to
handle correlations within the same hospital. The generalized
estimating equations method does not control for potential
confounding effects due to the different types of hospitals to
which patients are admitted. Therefore, hospital-level vari-
ables are included in the regression. Potential confounding
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designated risk characteristic outcome. These variables
included the following baseline characteristics: age, sex, race
(white, black/African American, Hispanic origin, other), BMI,
insurance status, atrial ﬁbrillation, chronic obstructive pulmo-
nary disease, diabetes mellitus, hyperlipidemia, hypertension,
peripheral vascular disease, prior myocardial infarction, heart
failure, dialysis, renal insufﬁciency, current/recent smoking,
United States Census–deﬁned geographic region, number of
beds, teaching status, and cardiac surgery on site. Age, BMI,
and number of beds were entered as continuous variables,
and missing values were imputed from the median. Age had
no missing data. Patients whose sex was missing from the
data were excluded from modeling because of concerns about
data quality for other variables. Insurance status was
categorized as Medicare, Medicaid, other insurance, and no
insurance. Less than 9% of insurance data were missing.
Patients ≥65 years of age were imputed to Medicare. All other
patients were imputed to other insurance, because this
category is more likely (no insurance or Medicaid is more
likely to be recorded by a data entry specialist). Medical
history panel variables were missing in 5.9% of patients;
missing values were imputed to “no” because of hypothesized
omissions. Race was missing in 2.3% of patients; missing
values were imputed to “white.” BMI was imputed to the sex-
speciﬁc median for 10.9% of patients (10.5% after exclusion of
patients with sex missing).
A variable was not included in the model as an independent
variable when that variable was the dependent variable. From
these models, unadjusted and adjusted odds ratios (ORs) for
the change in prevalence of each analyzed risk factor per
quarter–calendar-year increment were estimated, and results
were reported as the cumulative OR for the 6 years of the
study by exponentiating the OR per 1-year change to the
power of 6. Because there was evidence for statistical
interaction—that is, P<0.05—in several of the models (male
sex, diabetes mellitus, hypertension) when the interaction
term (time9STEMI/NSTEMI) was added to the above list of
confounders, results are reported separately for each stratum.
Sensitivity Analysis
Because sites both “dropped in” and “dropped out” over the
time interval of the study, a sensitivity analysis was performed
on only those sites that contributed at least 1 patient in 2003
or 2004 and at least 1 patient in each of the following years:
2005, 2006, 2007, and 2008. For this “core” data set
analysis, there were 73 715 patients from 78 unique sites.
All analyses were performed in SAS version 9.2 (SAS
Institute, Cary, NC). All signiﬁcance tests were 2 sided, and P
values <0.05 were considered statistically signiﬁcant. Given
the number of comparisons performed in this study, the lack
of adjustment for such multiple comparisons, and the large
overall sample size, a more conservative deﬁnition of
statistical signiﬁcance is suggested when P<0.001.
Results
Demographic Characteristics of Overall AMI
Patient Population Over Time: Univariate Analysis
As seen in Table 1, the change in age distribution over time for
the total sample was of borderline statistical signiﬁcance
(2003 median/IQR, 67/22 years; 2008 median/IQR, 66/22
years; P=0.0535). However, there was a signiﬁcant increase
over time in the relative proportion of patients between the
ages of 45 and 65 years (P<0.0001), and the relative
proportion of patients ≥65 years of age decreased
(P<0.0001). There was a signiﬁcant change in the sex ratio
(malesper 100females) from2003to2008, withanincreasing
proportion of females in later years (Figure 1A and 1B).
The distribution of racial/ethnic groups within the overall
sample exhibited a signiﬁcant change over time (Table 1),
with a decreasing proportion of Hispanics within the sample,
an increasing proportion of African Americans, and a relatively
constant proportion of white patients. There was also a
signiﬁcant change in the distribution of insurance status over
time (Table 1), with an initial increase in the proportion of
Medicaid and uninsured patients and a decrease in the
proportion of Medicare patients.
Clinical Characteristics and Risk Factors of
Overall AMI Patient Population Over Time:
Univariate Analysis
Ninety-three percent of the sample reported at least 1 risk
factor among 5 modiﬁable “classic” risk factors (hypertension,
hyperlipidemia, current smoking, diabetes mellitus, and
obesity), and 69% reported ≥2 such risk factors. The overall
prevalence of a history of hypertension remained high at
67.1% and varied little over time (2003, 67.6%; 2008, 68.5%; P
for trend=0.19). The prevalence of current or recent smoking
did not change signiﬁcantly (2003, 29.9%; 2008, 31.5%; P for
trend=0.74). The prevalence of a history of hyperlipidemia
increased (2003, 32.7%; 2008, 50.4%; P for trend <0.0001).
The prevalence of a BMI ≥30 kg/m
2 increased slightly, from
29.6% in 2003 to 30.3% in 2008 (P for trend <0.0001). The
overall prevalence of diabetes mellitus was 32.0% and
decreased over time from 33.2% to 31.7% (P for trend
<0.0001). The prevalence of total cholesterol >200 mg/dL
decreased from 18.5% in 2003 to 15.2% in 2008 (P for trend
<0.0001), and the prevalence of LDL >100 mg/dL initially
trended down from 2003 to 2006 and then seemed to
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Hstabilize from 2006 to 2008 (P for trend <0.0001). However,
the prevalence of “low” HDL (men, <40 mg/dL; women,
<50 mg/dL) increased from 40.1% in 2003 to 47.5% in 2008
(P for trend <0.0001). There was a signiﬁcant increase in the
proportion of patients with NSTEMI over time (Table 1).
Overall trends in the prevalence of key risk factors are
depicted in Figure 2.
There were notable differences between patients with
NSTEMI and patients with STEMI (Table 2). In general, patients
with NSTEMI were signiﬁcantly more likely to be older and
female and to have a greater burden of clinical risk factors—
for example, hypertension, diabetes mellitus, and prior myo-
cardial infarction. Conversely, patients with STEMI were more
likely to be younger, male, and active smokers and to have a
higher prevalence of biochemical risk factors—for example,
“low” HDL, “high” LDL, and triglycerides >150 mg/dL.
Demographic, Clinical, and Biochemical
Characteristics of Patients With STEMI Over
Time: Univariate Analysis
AsseeninTable 3,inpatientswithSTEMI,themedian/IQRagesin
2003and2008were,respectively,63/22 yearsand61/20 years
(Pfor trend<0.0001), and the proportion ofpatients ≥65 years of
agedecreased(P<0.0001).Theproportionofpatientsbetween45
and 65 years of age remained stable over time. The sex ratio
(number of males/100 females) increased over time (P=0.0002).
There was a slight but signiﬁcant decrease in the proportion of
non-Hispanic whites (P<0.0001) and a decrease in the proportion
of Hispanic patients over time (2003, 7.1%; 2008, 6.25%;
P<0.0001). There was a signiﬁcant decrease in the prevalence of
a history of diabetes mellitus (2003, 28.5%; 2008, 22.93%;
P<0.0001) and history of hypertension (2003, 63.06%; 2008,
70
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Figure 1. A, Distribution of women with AMI in 2003 (blue) and 2008 (red) in the AHA GWTG-CAD sample. Women >70 years of age comprised
the highest proportion of female patients with AMI. There was an increase in the percentage of patients (x-axis) in the 45- to 65-year age group
between 2003 and 2008. These age cohorts correspond to a signiﬁcant portion of the “Baby Boom” generation born between 1946 and 1964.
There is also an increase in the proportion of older women with AMI (>85 years) from 2003 to 2008. B, Distribution of men with AMI in 2003
(blue) and 2008 (red) in the AHA GWTG-CAD sample. Men between 55 and 65 years of age comprised the highest proportion of male patients
with AMI. There was an increase in the percentage of patients (x-axis) in the 45- to 65-year age group between 2003 and 2008. These age cohorts
correspond to a signiﬁcant portion of the “Baby Boom” generation born between 1946 and 1964. There is also an increase in the proportion of
older men with AMI (>85 years) from 2003 to 2008.
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H60.46%; P<0.0001), although the prevalence of a history of hyper-
lipidemiaincreased(2003,32.36%;2008,46.27%;P<0.0001).The
prevalence of smoking increased (2003, 37.22%; 2008, 41.76%;
P=0.0002). The prevalence of obesity increased (2003, 29.7%;
2008,30.82%;P<0.0001).Theprevalenceof“low”HDL(<40 mg/
dL in men, <50 mg/dL in women) increased signiﬁcantly (2003,
42.86%;2008,52.32%;P<0.0001),andtheprevalenceof“high”
LDL(LDL>100 mg/dL)increased(2003,37.2%;2008,39.95%;
P<0.0001), as did the prevalence of triglycerides >150 mg/dL
(2003, 26.27%; 2008, 27.02%; P=0.0004).
Demographic, Clinical, and Biochemical
Characteristics of Patients With NSTEMI Over
Time: Univariate Analysis
As seen in Table 4, in patients with NSTEMI, the median/IQR
ages in 2003 and 2008 were, respectively, 70/21 years and
69/22 years (P for trend=0.004). The proportion of patients
between 45 and 65 years of age increased slightly. In contrast
to the patients with STEMI, sex ratio decreased over time
(P<0.0001). There was a trend toward an increase in the
proportion of non-Hispanic whites, and the proportion of
Hispanic patients decreased over time (2003, 8.38%; 2008,
6.18%; P<0.0001). Consistent with the older age of patients
with NSTEMI, there was a higher proportion of Medicare-
insured patients. The prevalence of a history of diabetes
mellitus marginally decreased over time (2003, 35.62%; 2008,
35.55%; P=0.0327). The prevalence of a history of hyperten-
sion increased further over time (2003, 69.92%; 2008, 72.10%;
P=0.0162), and the prevalence of a history of hyperlipidemia
increased from 32.8% in 2003 to 52.21% in 2008 (P<0.0001).
There was a marginal increase in the prevalence of smoking
(2003, 26.08%; 2008, 26.91%; P=0.0224). The prevalence of
obesity increased marginally, from 29.57% in 2003 to 29.99%
in 2008 (P<0.0001). The prevalence of “low” HDL increased
from 38.65% in 2003 to 45.34% in 2008 (P<0.0001), whereas
the prevalence of “high” LDL decreased marginally (2003,
30.75%; 2008, 30.02%; P<0.0001).
Sensitivity Analysis
Sensitivityanalysisonthecoredataset(cf.Methods)indicated
excellent quantitative and qualitative agreement with the
overall data set ﬁndings. Speciﬁcally, the frequency of missing
medicalhistorydatawas6.35%inthecoredatasetand5.91%in
the overall data set. Median age (67 years) and mean age
(66.3 years) in the core data set were identical to the overall
dataset,andthetrendsovertimeweredirectionallysimilar.Sex
ratioswerenumericallysimilarinthecoreandoveralldatasets,
although the sex ratio trend in the core data set failed to reach
statistical signiﬁcance. Numerically and directionally similar
trends in the prevalences of diabetes mellitus, hypertension,
and hyperlipidemia were also in close agreement, as were the
trends in obesity prevalence and “low” HDL.
Trends in Clinical Characteristics and Risk
Factors of STEMI Patient Population:
Multivariable Analysis
After adjustment for multiple potential confounding variables,
including other risk factors (Table 5), the increase over time
in the proportion of patients between 45 and 65 years of age
was signiﬁcant, along with increases in the prevalences
of obesity and “low” HDL. However, there were signiﬁcant
Figure 2. Trends in prevalence of cardiovascular risk factors (age, sex, hypertension, diabetes mellitus, hyperlipidemia, obesity, smoking) from
2003 to 2008 in the overall GWTG-CAD AMI sample. *P<0.05 for trend. HTN indicates hypertension.
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diabetes mellitus, prior AMI, and current/recent smoking, as
well as decreases in the prevalences of “high” LDL and
triglycerides >150 mg/dL.
Trends in Clinical Characteristics and Risk
Factors of NSTEMI Patient Population:
Multivariable Analysis
After adjustment for multiple confounding variables, including
other risk factors (Table 6), there were signiﬁcant increases
over time in the proportion of patients between 45 and
65 years of age, whereas the proportion of “younger” patients
(≤45 years) decreased. The proportion of women increased
over time, as did the proportion of Hispanic patients. The
prevalence of diabetes mellitus decreased over time, whereas
the prevalence of obesity increased. The prevalence of “low”
HDL increased signiﬁcantly, whereas the prevalence of “high”
LDL decreased over time.
Sensitivity Analysis
In general, there was quantitative and qualitative agreement
between the core data sets and the overall stratum-speciﬁc
analyses. In the STEMI group, the analyses differed only in the
magnitude of the coefﬁcient for the decrease in hypertension
prevalence, whereas in the NSTEMI group, the analyses
differed only in the magnitude of the coefﬁcients for the
changes in sex ratio and hypertension prevalence.
Discussion
The present analysis of the clinical, demographic, and
biochemical characteristics of patients with AMI admitted
to hospitals participating in the AHA GWTG-CAD quality-
improvement initiative from 2003 to 2008 suggests that the
cumulative risk factor burden in patients with AMI remained
substantial. Favorable decreases in the prevalences of
several “classic” risk factors over this interval were offset
by increases in the prevalences of obesity and “low” HDL
and suggest that metabolic derangements are likely to
remain important contributors to overall risk factor burden.
The present observations are in agreement with previous
reports from dedicated registries of patients with AMI
12,13 and
population-based studies,
14,15 which described an increase in
the NSTEMI/STEMI ratio over time. Although some of this
increase has been attributed to a change in the diagnostic
criteria for AMI around 2000,
16 not all of the increase in the
proportion of NSTEMI can be attributed to this transi-
tion.
15,17,18 All patients in the present analysis were enrolled
from 2003 forward and thus were ascertained with standard-
ized post-transition criteria.
Our data are also in agreement with prior studies reporting
the risk factor burden in patients with AMI.
1–3 Despite high
prevalence of a history of hyperlipidemia and hypertension,
the recorded numerical values for admission blood pressure
(data not shown), LDL, and total cholesterol in the GWTG-CAD
registry are consistent with the increasing extent of antihy-
pertensive and lipid-lowering treatment in the general US
population.
19,20
The present data mirror previously reported magnitudes
and trends in the prevalence of obesity in AMI registries
12,13
Table 2. STEMI and NSTEMI Patient Proﬁle, 2003–2008
STEMI
(n=45 172)
NSTEMI
(n=92 950)
STEMI vs
NSTEMI
(P)
Age, y
Median 62 69 <0.0001
IQR 22 23
Mean 62.86 68.16
SD 14.15 14.2
Age ≤45 y, % 10.71 6.25 <0.0001
Age ≥65 y, % 43.33 60.14 <0.0001
Male, % 66.53 58.33 <0.0001
Race, %
Hispanic 7.15 7.34 <0.0001
Black or African American 6.51 7.79
White 75.55 74.36
Asian 2.87 3.32
Insurance status, %
None/UTD 12.86 6.95 <0.0001
Medicare 24.47 33.30
Medicaid 5.66 7.22
Other 48.41 44.49
Missing 8.60 8.03
Diabetes mellitus, % 25.56 35.12 <0.0001
Hypertension, % 60.60 70.21 <0.0001
Hyperlipidemia, % 44.44 47.85 <0.0001
Prior MI/CAD, % 23.24 32.60 <0.0001
Current/recent smoking, % 39.82 26.92 <0.0001
BMI ≥30 kg/m
2, % 30.17 30.37 0.0874
HDL <40 mg/dL (men),
<50 mg/dL (women), %
49.35 43.74 0.0283
LDL >100 mg/dL, % 37.92 30.30 <0.0001
Triglycerides >150 mg/dL, % 26.31 22.96 <0.0001
SD indicates standard deviation; STEMI, ST-segment elevation myocardial infarction;
NSTEMI, non-ST-segment elevation myocardial infarction; UTD, unable to determine; MI,
myocardial infarction; IRQ, interquartile range; CAD, coronary artery disease; BMI, body
mass index; HDL, high-density lipoprotein; and LDL, low-density lipoprotein.
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Hand population-based studies.
14,19,21 However, the increase in
the prevalence of obesity in the general population might not
be continuing at the same rate in more recent years.
22,23 The
small numerical, albeit statistically signiﬁcant, increase in the
prevalence of BMI ≥30 kg/m
2 in the present sample of
patients with AMI is in agreement with these latter reports.
The clinical relevance of an overall prevalence of obesity of
30% in this sample of patients with AMI should not be
overlooked, given the strong associations among obesity,
diabetes mellitus, hypertension, and dyslipidemia. The
observed downward trend in the unadjusted and adjusted
prevalences of diabetes mellitus in our study remains
unexplained and is at odds with prior observations in patients
with AMI,
12,13 although it is numerically consistent with a
more recent nested cohort population-based study.
15 The
present data should be viewed in the broader clinical context
of, on average, a prevalence of diabetes mellitus of 30% in
patients with AMI,
6,14,21 depending on the diagnostic criteria
used. The overall prevalence of diabetes mellitus was higher
in patients with NSTEMI, whereas the magnitude of change in
the prevalence of diabetes mellitus in patients with NSTEMI
was less than that observed in patients with STEMI, which
underscores the importance of stratum-speciﬁc analysis.
The additional information presented herein about a
signiﬁcant trend for the increase in prevalence of “low” HDL
is in agreement with previous reports of an increase in
prevalence of metabolic derangements in patients with AMI
24
as well as in the adult US population.
25
Implications of Changes in Demographic
Composition of the Current AMI Sample
The changes in the age and sex distributions of the GWTG-
CAD AMI population from 2003 to 2008, as shown in
Figure 1A and 1B, parallel the changes seen in the US
population in the ﬁrst decade of this century,
5 with the fastest
rate of growth noted in the 45- to 64-year age group.
5 This
group comprises the initial cohorts of the “Baby Boom”
generation as they enter the age range in which the risk of
AMI begins to increase steeply.
6 The increased prevalence of
poor cardiovascular health behaviors and health factors in
middle (40 to 64 years) and older (≥65 years) age groups in
the US population over the identical time period as the
present study provides additional insight into the correspon-
dence between speciﬁc characteristics in patients with AMI
and adults of similar age in the general population.
26 In a
separate report from the National Health and Nutrition
Examination Survey encompassing the years 1988–2010,
the prevalence of smoking decreased, and the prevalences of
desirable levels of untreated blood pressure and total
cholesterol were unchanged, whereas the prevalences of
desirable levels of BMI and fasting glucose decreased,
27
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general US population.
The public health implications and relevance of these
observations and correlations are clear.
28–30 The prevalence
of risk factors, and their trends over time, in patients with AMI
point to additional need for risk factor intervention at the
population level.
31,32 The present data from 2003 to 2008,
however, only begin to suggest a population momentum effect
resulting from the age cohorts comprising the “Baby Boom”
generation. Even static levels of age-speciﬁc prevalences,
when multiplied by the increasing number of subjects at risk
due to population momentum, will result in an increase in the
overall risk factor burden.
Limitations
The limitations of the present analysis relate chieﬂy to the use
of registry data. It is recognized that there are many potential
sources of selection bias in any registry and that the patients
in the AHA GWTG-CAD registry might not be representative of
all patients with AMI. Similarities to, as well as differences
from, the published literature have been noted. Participation
in the GWTG-CAD quality-improvement program is voluntary,
and as such, the program is likely to include higher-
performing hospitals. However, such potential selection bias
is unlikely to affect the type, or number, of patient(s)
presenting with an AMI, nor are the prevalences of underlying
risk factors likely to be affected. Data could be inﬂuenced by
both drop-in and drop-out of participating hospitals. Sensitivity
analysis limited to those hospitals participating in each year
revealed substantially similar trends and associations among
key risk factors, with few exceptions. Participation in the
GWTG-CAD program calls for consecutive enrollment of
patients, as is appropriate for performance (per Centers for
Medicare and Medicaid Services) and quality-improvement
(per Joint Commission) initiatives. Compliance, or the number
of patients enrolled per site per year, did not change over time
among core sites (P for trend=0.17). The analysis of data
collected over 6 years from >100 000 patients is likely to be
more representative of “real-world” patients with AMI than an
analysis from any one region or in any one year would be. The
GWTG-CAD program includes sites from all regions of the
Table 5. ORs for Outcomes for Calendar Quarter (Per 6-Year Increase) With Adjustment for Potential Confounders*: STEMI Group
Outcome
Total N
(45 172)
Unadjusted
OR
Lower
(95% CI for
Unadjusted
OR)
Upper
(95% CI for
Unadjusted
OR)
Unadjusted
P
Adjusted
OR
Lower (95% CI for
Adjusted OR)
Upper
(95% CI
for Adjusred
OR)
Adjusted
P
Demographics
Age ≤45 y 45 172 1.100 0.970 1.248 0.136 0.873 0.759 1.005 0.059
Age ≥65 y 45 172 0.756 0.685 0.835 <0.001 1.053 0.879 1.261 0.579
Age >45, <65 y 25 598 1.041 0.921 1.176 0.521 1.148 1.009 1.306 0.036
Sex, male 44 364 1.166 1.063 1.278 0.001 1.071 0.976 1.175 0.149
White race 44 077 1.021 0.796 1.310 0.869 1.010 0.780 1.307 0.942
Hispanic ethnicity 44 077 1.174 0.933 1.476 0.171 1.113 0.888 1.395 0.354
Medical history
Diabetes mellitus 42 051 0.671 0.595 0.757 <0.001 0.718 0.643 0.802 <0.001
Hypertension 42 051 0.800 0.700 0.915 0.001 0.813 0.704 0.939 0.005
Prior MI 42 051 0.681 0.589 0.787 <0.001 0.735 0.631 0.856 <0.001
Current or recent
smoking
44 112 0.984 0.898 1.078 0.727 0.890 0.802 0.987 0.028
Laboratories
BMI ≥30 kg/m
2 40 478 1.264 1.146 1.394 <0.001 1.232 1.119 1.357 <0.001
LDL >100 mg/dL 32 264 0.789 0.708 0.879 <0.001 0.688 0.605 0.781 <0.001
HDL <40 mg/dL (men),
<50 mg/dL (women)
32 593 1.588 1.357 1.859 <0.001 1.667 1.396 1.992 <0.001
TG >150 mg/dL 32 641 0.866 0.767 0.978 0.020 0.821 0.731 0.922 <0.001
COPD indicates chronic obstructive pulmonary disease; CI, conﬁdence interval; MI, myocardial infarction; TIA, transient ischemic attack; TG, triglycerides; STEMI, ST-segment elevation
myocardial infarction; BMI, body mass index; LDL, low-density lipoprotein; and HDL, high-density lipoprotein.
*Variables in the model: age, sex, race (white, black, Hispanic, other), BMI, insurance, atrial ﬁbrillation, COPD/asthma, cerebrovascular accident/TIA, diabetes mellitus, hyperlipidemia,
hypertension, peripheral vascular disease, prior MI, heart failure, dialysis, renal insufﬁciency, smoking, geographic region, number of beds, teaching status, and cardiac surgery on site.
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community-based hospitals. Patients in the GWTG-Stroke
performance-improvement program, a group not substantially
dissimilar from patients with AMI with regard to cardiovas-
cular risk factors, have been shown to be similar to patients in
non–GWTG-participating centers.
33 However, at the present
time, there are no comparable studies in patients with CAD/
AMI. Changes in professional and societal awareness of the
presence and importance of sex-speciﬁc differences in
cardiovascular disease at the time of this study
34 could have
had an important, albeit unquantiﬁable, effect on our ﬁndings.
However, a recent study failed to identify differences in the
time to hospital presentation among women with AMI after a
national awareness campaign.
35
Data were collected by chart review and are dependent on
the accuracy and completion of documentation and abstrac-
tion. All data are entered at the site by highly trained
individuals with experience in data entry. The GWTG database
features carefully deﬁned data entries, standardized diagnostic
criteria throughout, and regular quality assessment. Impor-
tantly, the GWTG database includes only patients with
conﬁrmed AMI diagnosis at discharge and avoids many of
the sources of information bias when the diagnosis is based
on admission characteristics. These data and inferences from
the data could, however, be limited by potential bias resulting
from the inability of disadvantaged and minority groups to
access medical care. Such patients are not, by deﬁnition,
included in the GWTG-CAD data set and cannot be evaluated.
The inferences with regard to changes in the prevalence of
risk factors suggested by these data apply to the overall
patient population.
The magnitudes of the reported main outcome measures of
association—the OR for a change in prevalence of a given risk
factor per 1 year—were small and initially suggested little
clinically signiﬁcant change from year to year, despite their
statistical signiﬁcance. We chose to report the cumulative OR
for the change in prevalence of characteristics over the 6-year
observation period in an effort to underscore their clinical
signiﬁcance. Statistical methodology dictates that the
(adjusted) ORs must be interpreted in the context of all other
covariates being ﬁxed. From clinical and epidemiological
perspectives,multiplecovariates arenotinfrequentlyidentiﬁed
Table 6. ORs for Outcomes for Calendar Quarter (Per 6-Year Increase) With Adjustment for Potential Confounders*: NSTEMI
Group
Outcome
Total N
(92 950)
Unadjusted
OR
Lower
(95% CI for
Unadjusted
OR)
Upper
(95% CI for
Unadjusted
OR)
Unadjusted
P
Adjusted
OR
Lower
(95% CI for
Adjusted OR)
Upper
(95% CI for
Adjusted OR)
Adjusted
P
Demographics
Age ≤45 y 92 950 0.884 0.776 1.008 0.065 0.804 0.689 0.939 0.006
Age ≥65 y 92 950 1.014 0.943 1.090 0.715 1.168 0.975 1.400 0.093
Age >45, <65 y 37 051 1.157 1.024 1.308 0.019 1.213 1.054 1.396 0.007
Sex, male 91 401 0.896 0.833 0.964 0.003 0.921 0.850 0.997 0.043
White race 90 866 1.264 0.850 1.879 0.247 1.059 0.730 1.535 0.762
Hispanic ethnicity 90 866 1.211 1.065 1.377 0.003 1.232 1.101 1.379 <0.001
Medical history
Diabetes mellitus 87 903 0.920 0.852 0.994 0.034 0.888 0.814 0.968 0.007
Hypertension 87 903 1.003 0.884 1.138 0.965 0.886 0.779 1.007 0.065
Prior MI 87 903 0.703 0.589 0.840 <0.001 0.706 0.591 0.844 <0.001
Current or recent smoking 90 591 0.867 0.798 0.943 <0.001 0.944 0.858 1.038 0.232
Laboratories
BMI ≥30 kg/m
2 82 649 1.192 1.112 1.278 <0.001 1.233 1.147 1.325 <0.001
LDL >100 mg/dL 59 362 0.726 0.669 0.787 <0.001 0.665 0.604 0.732 <0.001
HDL <40 mg/dL (men),
<50 mg/dL (women)
60 008 1.437 1.232 1.677 <0.001 1.657 1.388 1.978 <0.001
TG >150 mg/dL 60 211 0.736 0.675 0.801 <0.001 0.733 0.665 0.807 <0.001
COPD indicates chronic obstructive pulmonary disease; CI, conﬁdence interval; MI, myocardial infarction; TIA, transient ischemic attack; TG, triglycerides; NSTEMI, non-ST-segment
elevation myocardial infarction; BMI, body mass index; LDL, low-density lipoprotein; and HDL, high-density lipoprotein.
*Variables in the model: age, sex, race (white, black, Hispanic, other), BMI, insurance, atrial ﬁbrillation, COPD/asthma, cerebrovascular accident/TIA, diabetes mellitus, hyperlipidemia,
hypertension, peripheral vascular disease, prior MI, heart failure, dialysis, renal insufﬁciency, smoking, geographic region, number of beds, teaching status, and cardiac surgery on site.
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hypertension, and obesity. Statistical attempts to “isolate”
changes in one of several highly associated variables might
result inunstableormisleadingestimatesofatrueassociation.
It is acknowledged that the use of an OR as an
approximation of relative risk, or risk ratio, is problematic
when prevalence is high. The majority of the characteristics
and risk factors reported here have a high prevalence, and
calculation of prevalence ratios and their changes would be
more appropriate.
36 However, qualitative inferences from this
study remain valid.
In conclusion, the present analysis, based on >100 000
patients with AMI from 2003 to 2008, indicates that there
were clinically and statistically signiﬁcant changes over time
in the risk factors and characteristics assessed. Increases in
the prevalence of women, NSTEMI, and patients 45 to
65 years of age, when viewed from an epidemiological
perspective, have important implications for the identiﬁcation
of further opportunities for risk factor modiﬁcation. Continued
increases in the prevalence of obesity and low HDL over the
next decade, along with persistently high prevalences of
hypertension and diabetes mellitus, particularly in the growing
segment of patients with NSTEMI, could offset the beneﬁcial
clinical effects of decreasing trends in other risk factors and
could result in higher disease burden and post-AMI morbidity
in AMI survivors.
37
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